New Medscape Educational Activity for clinicians helps them identify common risks and devise optimal strategies for challenging scenarios.
Genentech receives breakthrough therapy designation from the FDA for ACE910 subcutaneous therapy for hemophilia A.
FDA approves expanded use of Octapharma's WILATE for surgery in patients with VWD.
“Rare Coagulopathies” chapter provides an overview of rare factor deficiencies and platelet disorders.
FX Producer of American Horror Story: Hotel refers to vampirism of a new character as “an ancient blood virus” that’s “really a form of hemophilia in a way.”
Apply now for the Prix Henri Chaigneau award, the winner to be announced at WHF's 2016 World Congress in Orlando, FL, July 2016.
"It Doesn't Have to Hurt,” new Canadian social media campaign, aims to improve parents’ use of pain management methods in their children.
Latest Medscape activity discusses emerging data for managing hemophilia and helps clinicians evaluate how to use them in clinical practice.
NHF is partnering with McMaster University, an international leader on clinical practice guidelines, to develop evidence-based guidelines for hemophilia care.
Bristol-Myers Squibb’s Daklinza™ (daclatasvir) combined with Gilead 's Sovaldi®,and AbbVie Inc.’s Technivie™ had high success rates in clearing hepatitis C virus.
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car